Galang, Gilyn S.

HRN: 22-34-44  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2022
CEFUROXIME 1.5GM (VIAL)
12/30/2022
12/30/2022
IV
1.5gms
On Call To OR
Direct CS
Waiting Final Action 
12/30/2022
CEFUROXIME 1.5GM (VIAL)
12/30/2022
01/01/2023
IV
1.5 Gms
Q8
LTCS
Waiting Final Action 
12/30/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/30/2022
01/01/2023
IVT
500mg
Q 8 Hrs
LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: